Bausch + Lomb Corporation (BLCO)
NYSE · Healthcare
Bausch + Lomb Corporation Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 5.10B | 4.79B | 4.15B | 3.77B | 3.77B | 3.41B |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | 113.0M | 162.0M | 130.0M | 207.0M | 329.0M | 260.0M |
| EBITDA | 534.0M | 598.0M | 512.0M | 586.0M | 744.0M | 702.0M |
| Net Income | -360.0M | -317.0M | -260.0M | 6.0M | 182.0M | -18.0M |
| Per Share Data | ||||||
| EPS (diluted) | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 354M | 352M | 351M | 350M | 350M | 350M |
Bausch + Lomb Corporation Income Statement — FAQ
Bausch + Lomb Corporation (BLCO) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BLCO's income statement history?
The chart and table above show Bausch + Lomb Corporation's income statement by year and by quarter, including the growth rate.